Phibro Animal Health Corporation
PAHC
$43.37
$1.313.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.22M | 20.88M | 3.19M | 6.98M | 752.00K |
| Total Depreciation and Amortization | 10.99M | 12.62M | 11.57M | 9.00M | 7.77M |
| Total Amortization of Deferred Charges | 1.99M | 572.00K | 504.00K | 367.00K | 1.70M |
| Total Other Non-Cash Items | 5.32M | 658.00K | 5.51M | -5.68M | -2.68M |
| Change in Net Operating Assets | -14.25M | 8.43M | -17.69M | 1.96M | 20.90M |
| Cash from Operations | 21.27M | 43.15M | 3.08M | 12.62M | 28.43M |
| Capital Expenditure | -13.14M | -7.75M | -7.82M | -9.58M | -13.07M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 5.35M | -1.05M | -290.83M | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 759.00K | -9.45M | 38.17M | 6.65M | 3.96M |
| Cash from Investing | -7.03M | -18.25M | -260.47M | -2.93M | -9.11M |
| Total Debt Issued | 60.53M | 81.00M | 481.00M | 567.00M | 129.59M |
| Total Debt Repaid | -68.62M | -107.06M | -197.88M | -579.02M | -125.60M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.86M | -4.87M | -4.86M | -4.86M | -4.86M |
| Other Financing Activities | 5.19M | -1.30M | -1.95M | -12.32M | 2.66M |
| Cash from Financing | -7.77M | -32.22M | 276.32M | -29.20M | 1.79M |
| Foreign Exchange rate Adjustments | 1.21M | 600.00K | -3.69M | 729.00K | -717.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.69M | -6.72M | 15.24M | -18.78M | 20.39M |